CTT Pharmaceutical Adds Karen Larson as Independent Board Member

What Happened CTT Pharmaceutical Holdings, Inc. (OTCQB: CTTH) announced in an 8-K filed September 23, 2026 (Item 8.01) that it has added Karen Larson to its board as an Independent Board Member. The filing summarizes Mrs. Larson’s background in finance and business leadership.

Key Details

• Appointment: Karen Larson named Independent Board Member (8-K filed Sept 23, 2026).
• Professional background: Certified Financial Planner (CFP); former Senior Vice President, Investment Banker at Chase Manhattan Bank.
• Entrepreneurial experience: Founded an analytical reporting business that was sold to Morningstar.
• Recent activity: Since 2017, Larson has been a founder of Broad Avenue Studios, Inc., a commercial and residential real estate company.

Why It Matters Adding an independent director with financial, investment banking and entrepreneurial experience can affect corporate governance and board oversight. For investors, this is a governance update rather than an operational or financial disclosure—no compensation terms, executive changes, or financial results were included in the filing.